Conflicting evidence on the frequency of ESR1 amplification in breast cancer

Donna G. Albertson

doi:10.1038/ng0708-821

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

Donna G. Albertson

Oral and Maxillofacial Surgery

Research output: Contribution to journal › Short survey › peer-review

Abstract

An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

Original language	English (US)
Pages (from-to)	821-822
Number of pages	2
Journal	Nature Genetics
Volume	40
Issue number	7
DOIs	https://doi.org/10.1038/ng0708-821
State	Published - Jul 2008

ASJC Scopus subject areas

Genetics

Access to Document

10.1038/ng0708-821

Cite this

@article{cf0039bd841345128936b184326e5cfe,

title = "Conflicting evidence on the frequency of ESR1 amplification in breast cancer",

abstract = "An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.",

author = "Albertson, {Donna G.}",

year = "2008",

month = jul,

doi = "10.1038/ng0708-821",

language = "English (US)",

volume = "40",

pages = "821--822",

journal = "Nature Genetics",

issn = "1061-4036",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Conflicting evidence on the frequency of ESR1 amplification in breast cancer

AU - Albertson, Donna G.

PY - 2008/7

Y1 - 2008/7

N2 - An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

AB - An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

UR - http://www.scopus.com/inward/record.url?scp=46249125768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249125768&partnerID=8YFLogxK

U2 - 10.1038/ng0708-821

DO - 10.1038/ng0708-821

M3 - Short survey

C2 - 18583976

AN - SCOPUS:46249125768

SN - 1061-4036

VL - 40

SP - 821

EP - 822

JO - Nature Genetics

JF - Nature Genetics

IS - 7

ER -

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this